Megan Smeykal Tela Bio, Inc. (TELA) insider trading activity

Megan Smeykal is Chief Accounting Officer of TELA Bio, Inc.. Currently has a direct ownership of 36,831 shares of TELA, which is worth approximately $45,670. The most recent transaction as insider was on Mar 31, 2025, when has been sold 96 shares (Common Stock) at a price of $1.22 per share, resulting in proceeds of $117. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 36.8K

27.0% 3M change

27.0% 12M change

Total Value Held $45,670

Megan Smeykal Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Mar 31 2025	SELL Payment of exercise price or tax liability	$117 $1.22 p/Share	96 Reduced 0.26%	36,831 Common Stock
Feb 24 2025	SELL Payment of exercise price or tax liability	$1,428 $2.65 p/Share	539 Reduced 1.44%	36,927 Common Stock
Feb 23 2025	SELL Payment of exercise price or tax liability	$1,150 $2.72 p/Share	423 Reduced 1.12%	37,466 Common Stock
Feb 21 2025	SELL Payment of exercise price or tax liability	$4,324 $2.72 p/Share	1,590 Reduced 4.03%	37,889 Common Stock
Feb 19 2025	BUY Grant, award, or other acquisition	-	9,400 Added 19.23%	39,479 Common Stock
Mar 31 2024	SELL Payment of exercise price or tax liability	$544 $5.67 p/Share	96 Reduced 0.33%	29,000 Common Stock
Feb 24 2024	SELL Payment of exercise price or tax liability	$3,810 $7.07 p/Share	539 Reduced 1.82%	29,096 Common Stock
Feb 23 2024	SELL Payment of exercise price or tax liability	$2,990 $7.07 p/Share	423 Reduced 1.41%	29,635 Common Stock
Feb 21 2024	SELL Payment of exercise price or tax liability	$5,565 $7.0 p/Share	795 Reduced 3.71%	20,658 Common Stock
Feb 21 2024	BUY Grant, award, or other acquisition	-	9,400 Added 23.82%	30,058 Common Stock
Mar 31 2023	SELL Payment of exercise price or tax liability	$1,021 $10.64 p/Share	96 Reduced 0.47%	20,431 Common Stock
Feb 24 2023	SELL Payment of exercise price or tax liability	$5,945 $11.03 p/Share	539 Reduced 2.56%	20,527 Common Stock
Feb 23 2023	SELL Payment of exercise price or tax liability	$4,441 $10.5 p/Share	423 Reduced 1.97%	21,066 Common Stock
Feb 21 2023	BUY Grant, award, or other acquisition	-	9,400 Added 30.43%	21,489 Common Stock
Mar 31 2022	SELL Payment of exercise price or tax liability	$1,082 $11.63 p/Share	93 Reduced 0.76%	12,089 Common Stock
Feb 24 2022	SELL Payment of exercise price or tax liability	$6,409 $11.98 p/Share	535 Reduced 4.21%	12,182 Common Stock
Feb 23 2022	BUY Grant, award, or other acquisition	-	5,000 Added 28.22%	12,717 Common Stock

Megan Smeykal

Chief Accounting Officer

Malvern, PA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TELA shares.

Notify only if

Value

Insider Trading

Get notified when an Tela Bio, Inc. insider buys or sells TELA shares.

Notify only if

Operation

Value

Type

News

Receive news related to TELA Bio, Inc.

Track Activities on TELA

Account